
The Hellenic Association of Pharmaceutical Companies (SFEE) held the second 1roundtable in its “Innovation Meets Industry” initiative, bringing together drugmakers, startups, university spin-offs and investors to discuss how Greece can strengthen links between research and commercial healthcare innovation.
The May 14 meeting, organized with Industry Disruptors – Game Changers, focused on practical examples of collaboration rather than policy theory. Participants discussed investment activity, technology transfer, financing barriers and the difficulties Greek health startups face in moving from academic research into market-ready products.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze